A compound that could disrupt the series of events that induce damage to the retina in diabetic retinopathy, been keyed by researchers at the University of Michigan Kellogg Eye Center. The finding is significant because it could lead to a novel therapy that targets two mechanisms at the root of the disease: inflammation and the weakening of the blood barrier that protects the retina. To date, treatments for diabetic retinopathy, the leading cause of blindness ...
via Medindia Health News
More READ
No comments:
Post a Comment